tradingkey.logo

Vaccine makers rise after White House withdraws pick for CDC director

ReutersMar 13, 2025 2:22 PM

Shares of vaccine makers Moderna MRNA.O, Novavax NVAX.O and Pfizer PFE.N gain as White House withdraws nomination of vaccine critic Dave Weldon to serve as director of the U.S. Centers for Disease Control and Prevention

Moderna MRNA.O climbs 4.17% to $36.47, Novavax NVAX.O rises 1.85% to $8.25 and Pfizer PFE.N up marginally

The former Republican congressman had been scheduled to appear before the Senate Health, Education, Labor and Pensions Committee on Thursday for a confirmation hearing

The committee confirmed the withdrawal of the nomination and said the hearing had been canceled

The stocks have been under pressure since Trump was elected for a second term, and selected well-known vaccine skeptic Robert F. Kennedy Jr to lead the Department of Health and Human Services, U.S.'s top health agency

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI